Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide

TCM (Traditional Chinese Medicine) Therapeutic Actions Moistens the Lungs (beneficial for dry cough or heat patterns) Transforms Phlegm (breaks down congestion and mucus) Opens the Airways (improves breath flow and oxygenation) Releases the Exterior (used in Wind-Heat invasion, colds) Clears Heat and Toxins (targeting pathogens and inflammation) Common TCM Constitutional Diagnoses: Lung Qi Deficiency fatigue, frequent colds Phlegm-Damp in the Lungs chest heaviness, congestion Wind-Heat Invasion sore throat, acute illness Lung Yin Deficiency dry throat, hoarse voice Cautions & Contraindications Possible Side Effects May Include : Jitters, headache, irregular heartbeat Coughing, throat irritation, swelling Redness, difficulty swallowing, breathing difficulty Herxheimer reaction (temporary symptom flare-up during detox) Skin rash, fatigue, nausea, diarrhea Rare allergic reactions Legal Statement: This therapy must be prescribed and administered under professional supervision

Compounded preparations combining BPC-157 and TB-500 are dispensed by licensed 503A pharmacies pursuant to a patient-specific prescription based on a documented clinical evaluation
In irradiated 3T3 fibroblasts, GHK treatment decreased the expression of p21, a key marker of cellular senescence (Figure 2A)